Back
FutureFuel Corp. 10K Form
Buy
52
FF
FutureFuel Corp.
Last Price:
$4.19
Seasonality Move:
0.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | FF/FutureFuel Corp. Quarterly |
| 2023-11-09 | 10Q | FF/FutureFuel Corp. Quarterly |
| 2023-08-09 | 10Q | FF/FutureFuel Corp. Quarterly |
| 2023-05-09 | 10Q | FF/FutureFuel Corp. Quarterly |
| 2022-11-09 | 10Q | FF/FutureFuel Corp. Quarterly |
| 2022-08-08 | 10Q | FF/FutureFuel Corp. Quarterly |
Receive FF News And Ratings
See the #1 stock for the next 7 days that we like better than FF
FF Financial Statistics
Sales & Book Value
| Annual Sales: | $95.7M |
|---|---|
| Cash Flow: | $-29.9M |
| Price / Cash Flow: | 10.81 |
| Annual Sales: | $3.53 |
| Price / Book: | 1.19 |
Profitability
| EPS (TTM): | -1.12660 |
|---|---|
| Net Income (TTM): | $-49.4M |
| Gross Margin: | $-40.7M |
| Return on Equity: | -27.56% |
| Return on Assets: | -21.91% |
FutureFuel Corp. Earnings Forecast
Key FutureFuel Corp. Financial Ratios
-
The Gross Profit Margin over the past 20 years for FF is -42.50%.
-
The Selling, General & Administrative Expenses for FF have been equal to 10.13% of Gross Profit Margin.
-
The Research & Development expenses have been 4.04% of Revenue.
-
The Net Earning history of FF is -51.59% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 9 years.
FutureFuel Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | FF |
| CUSIP: | 36116M |
| Website: | futurefuelcorporation.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.67 |
| Quick Ratio: | 3.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.06 |
|---|---|
| Forward P/E Ratio: | 0 |
FF Technical Analysis vs Fundamental Analysis
Buy
52
FutureFuel Corp. (FF)
is a Buy
Is FutureFuel Corp. a Buy or a Sell?
-
FutureFuel Corp. stock is rated a BuyThe current FutureFuel Corp. [FF] share price is $4.18. The Score for FF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.